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Background: In osteoporosis, bone loss is accompanied by increased marrow adiposity. Given their proximity in
the bone marrow and their shared origin, a dialogue between adipocytes and osteoblasts could be a factor in
the competition between human Mesenchymal Stem Cells (hMSC) differentiation routes, leading to adipocyte
differentiation at the expense of osteoblast differentiation. The adipocyte/osteoblast balance is highly regulated at
the level of gene transcription. In our work, we focused on PPARgamma, CEBPalpha and CEBPdelta, as these
transcription factors are seen as master regulators of adipogenesis and expressed precociously, and on leptin and
adiponectin, considered as adipocyte marker genes. In 2010, our group has demonstrated, thanks to a coculture
model, that in the presence of hMSC-derived adipocytes (hMSC-Adi), hMSC-derived osteoblasts (hMSC-Ost) express
lesser amounts of osteogenic markers but exhibit the expression of typical adipogenic genes. Nevertheless, the
mechanisms underlying this modulation of gene expression are not clarified. Recently, adipocytes were described
as releasing extracellular vesicles (EVs), containing and transferring adipocyte specific transcripts, like PPARgamma,
leptin and adiponectin. Here, we investigated whether EVs could be the way in which adipocytes transfer
adipogenic RNAs in our coculture model.
Results: We observed in hMSC-Ost incubated in hAdi-CM an increase in the adipogenic PPARγ, leptin, CEBPα and
CEBPδ transcripts as well as the anti-osteoblastic miR-138, miR30c, miR125a, miR-125b, miR-31 miRNAs, probably
implicated in the observed osteocalcin (OC) and osteopontin (OP) expression decrease. Moreover, EVs were isolated
from conditioned media collected from cultures of hMSC at different stages of adipocyte differentiation and these
specific adipogenic transcripts were detected inside. Finally, thanks to interspecies conditioned media exposition,
we could highlight for the first time a horizontal transfer of adipogenic transcripts from medullary adipocytes
to osteoblasts.
Conclusions: Here, we have shown, for the first time, RNA transfer between hMSC-derived adipocytes and osteoblasts
through EVs. Additional studies are needed to clarify if this mechanism has a role in the adipocytic switch driven on
osteoblasts by adipocytes inside bone marrow and if EVs could be a target component to regulate the competition
between osteoblasts and adipocytes in the prevention or in the therapy of osteoporosis and other osteopenia.
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Maintenance of healthy bone mass requires a conti-
nuous process of bone renewal, known as bone remo-
delling, which consists of a balance of bone resorption
by osteoclasts and bone formation by osteoblasts. The
decrease in bone mass that occurs in osteoporosis re-
sults from the impairment of this balance, leading to in-
creased fracture risk. Additional evidence from in vitro,
in vivo and clinical studies also supports a link between
bone loss and accumulation of medullary adipocytes
[1-5]. Situations such as aging, estrogen insufficiency [6],
anorexia nervosa [7], diverse therapies [8], microgravity
exposure [9], or factors such as miRNAs [10,11] are
known to induce bone loss concurrently with enhanced
bone marrow adiposity. Evidence shows that a dialogue
between adipocytes and osteoblasts is one of the mecha-
nisms occurring in the competition between human
Mesenchymal Stem Cells (hMSC) differentiation routes,
supporting adipocyte differentiation at the expense of
osteoblast differentiation. Consequently, factors which
promote adipogenesis not only lead to “fatty marrow”
but also inhibit osteoblastogenesis or osteoblast prolifer-
ation, resulting in decreased osteoblast numbers, dimin-
ished bone formation and, potentially, loss of bone mass
leading to osteoporosis [12,13]. The adipocyte/osteoblast
balance is highly regulated at the level of gene trans-
cription [14]. It is difficult to find specific adipogenic
mRNAs that are not shared by osteoblasts [15,16]. In
our work, we focused on one side on PPARγ, CEBPα
and CEBPδ, as these transcription factors are seen as the
master regulators of adipogenesis [17] and are expressed
precociously, and on the other side on leptin and
adiponectin, considered as adipocyte marker genes
increasing in a time-dependent manner during adipo-
genic induction [15].
In 2010, our group has demonstrated, using a coculture
model [18], that in the presence of hMSC-derived adipo-
cytes (hMSC-Adi), hMSC-derived osteoblasts (hMSC-Ost)
express lower amounts of osteogenic markers but exhibit
expression of typical adipogenic genes. Nevertheless, the
mechanisms underlying this modulation of gene ex-
pression are not clarified. Extracellular Vesicles (EVs) are
100 nm to 1 μm membrane-bound structures released
from the plasma membrane of most cell types and are in-
volved in a range of physiological processes, including
angiogenesis, inflammation, progression of cancers and re-
programming of mesenchymal stem cells, especially by
transferring RNAs [19]. Recently, primary rat and cultured
mouse adipocytes were described as releasing EVs [20].
They have been shown to contain adipocyte specific tran-
scripts, like leptin and adiponectin, that are both trans-
ferred into and expressed in acceptor adipocytes and
are involved in the upregulation of lipogenesis and cell
size [21]. Moreover, adipocyte-derived vesicles weredemonstrated to transfer adipocyte-specific gene tran-
scripts such as adiponectin, resistin, and PPARγ2 into
RAW264.7 macrophages [22].
Here, we considered if EVs could be the mechanism
by which adipocytes transfer adipogenic RNAs in our
coculture model. To confirm this hypothesis, we incu-
bated hMSC-Ost in conditioned medium obtained from
hMSC-Adi (hAdi-CM) cultures. We observed in the
osteoblastic population an increase in the adipogenic
PPARγ, leptin, CEBPα and CEBPδ transcripts, dependent
on mRNA amount as shown by conditioned media
obtained from adipocytes at several differentiation stages
and PPARγ silencing experiments, as well as the anti-
osteoblastic miR-138, miR30c, miR125a, miR-125b, miR-31
miRNAs [23-26], probably implicated in osteocalcin (OC)
and osteopontin (OP) expression decrease. Moreover, we
isolated EVs from conditioned media collected from cul-
tures of hMSC at different stages of adipocyte differenti-
ation and detected inside the presence of these specific
adipogenic transcripts. Finally, thanks to inter-species
conditioned media exposition, and using species specific
primers, we could highlight for the first time a horizontal
transfer of adipogenic transcripts from medullary adipo-
cytes to osteoblasts. Here, we postulate that hMSC-
derived adipocytes are able to produce EVs responsible for
the transfer of adipogenic RNAs to osteoblasts.
Results
Adipocyte-specific RNA expression is increased in
osteoblasts by hMSC-derived adipocyte conditioned
media and influence osteoblast markers expression
hMSC-Ost and hMSC-Adi were obtained as described in
Materials and Methods. We examined if hMSC-Ost incu-
bation during 48 h in conditioned media issued from
hMSC-Adi (hAdi-CM) after 0, 7, 14 and 21 days of diffe-
rentiation, lead to a variation of adipocyte and osteoblast
specific gene expression in osteoblasts. First, we measured
by RT-qPCR expression levels of the four adipocyte-
specific genes PPARγ, leptin, CEBPα and CEBPδ and rela-
tive quantification was performed on the reference gene
YWHAZ. As shown in Figure 1A, relative expression
levels of the four genes were directly dependent on the
stage of differentiation of the hMSC-Adi. The maximal in-
crease was reached with the CM obtained after 14 days of
adipocyte differentiation for all of the genes. For this rea-
son, miRNA and osteoblasts mRNA levels were measured
in hMSC-Ost incubated in conditioned medium from adi-
pocytes differentiated for 14 days. Five miRNAs, miR-138,
miR-30c, miR-125a, miR-125b and miR-31, were selected
for their capacity to inhibit osteoblast gene expression
[25-28]. As shown in Figure 1B, all of them showed an in-
crease in their expression in hMSC-Ost incubated with
14 days differentiated hAdi-CM. Furthermore, incubation
of hOst D14 with hAdi D14 CM led to a slight but
Figure 1 Adipocyte- and osteoblast-specific mRNA and miRNA quantification in osteoblasts incubated with hMSC-0, 7, 14 and 21 days
differentiated adipocyte medium. (A) RT-qPCR analysis of PPARγ, Leptin, CEBPα and CEBPδ in 14 days-differentiated osteoblasts incubated with
conditioned medium from 0, 7, 14, and 21 days-differentiated adipocytes (hAdi-CM). Transcript levels of YWHAZ were used for sample normalization
[29]. Data was obtained from 4 independent experiments (Bars: median ± interquartile space). Differences were considered significant at p < 0.05
(*p < 0.05). (B) RT-qPCR analysis of miR-138, miR-30c, miR-125a, miR-125b, miR-31 in 14 days-differentiated osteoblasts incubated with conditioned
medium from 14 days-differentiated adipocytes (hAdi-CM). Transcript levels of RNU6P were used for sample normalization. Data was obtained from 3
independent experiments (Bars: median ± interquartile space). (C) RT-qPCR analysis of OC and OP in 14 days-differentiated osteoblasts incubated with
conditioned medium from 0 (ctrl) or 14 days-differentiated adipocytes (hAdi D14-CM). Transcript levels of YWHAZ were used for sample normalization.
Data was obtained from 3 independent experiments (Bars: median ± interquartile space). For (A), (B) and (C) control (ctrl) was performed by incubating
hMSC-derived osteoblasts with serum- and inductors-free DMEM for the same time.
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ation markers of gene expression, osteocalcin (OC) and
osteopontin (OP) (Figure 1C), supporting the idea that at
least some of the transferred miRNAs are functional.
Taken together, these results indicate that some
compounds are secreted by differentiated hMSC-Adi
leading to an increase in specific pro-adipogenic or anti-
osteoblastic RNAs in osteoblasts.
hMSC-Adi express adipogenic mRNAs and anti-osteoblastic
miRNAs proportionally as those found in hMSC-Ost
incubated in hAdi-CM
We wanted to confirm the increase in the same specific
RNAs in hMSC-derived adipocytes at 0, 7, 14 and 21 days
of differentiation as in osteoblasts incubated with the
corresponding conditioned media. Figure 2A shows repre-
sentative images of the differentiating hAdi used for the
generation of CM. Appearance of lipid droplets after
7 days of differentiation whose number increases at 14
and 21 days were observed, as expected. In addition,
Figure 2B shows that hMSC-Adi expressed increasing
amounts of the four studied adipogenic mRNAs, depen-
ding on the stage of differentiation. More precisely,
PPARγ, CEBPα and CEBPδ reached a maximal level of
expression after 7 days of differentiation whereas the
maximal level of leptin expression was reached after14 days of differentiation, with no mRNA detected at day
0. Concerning the studied miRNAs, their expression was
enhanced in 14 days differentiated hMSC-Adi (Figure 2C).
Furthermore, silencing experiments were performed to
examine if knockdown of PPARγ mRNA in the donor
adipocytes leads to a reduction of the corresponding
RNA in the recipient osteoblasts after conditioned me-
dium transfer. hAdi D14 were transfected with siRNA
targeting PPARγ mRNA and a substantial decrease
(more than 95%) could be obtained (Figure 2D). Incu-
bation of hOst D14 with the subsequent conditioned
medium (hAdi D14 siPPARγ CM) really led to a re-
duction of PPARγ mRNA in the recipient osteoblasts
compared to those incubated with hAdi D14 CM
(Figure 2E).
In conclusion, the expression of RNAs found in
hMSC-Ost incubated with hAdi-CM follows the same
tendency as those found in hMSC-Adi from which the
CM is obtained, suggesting RNA transfer between the
two cell types.
Extracellular vesicles harbouring adipogenic mRNAs are
found in hAdi-CM
We wanted to investigate if EVs can be one of the vec-
tors taking part in the adipocyte gene rise described
above. As a first confirmation, hMSC-Adi EVs were
Figure 2 Observation and adipogenic-specific RNAs quantification of adipocytes at 0, 7, 14 and 21 days of differentiation. (A) Images
obtained by optical microscopy on human MSC-derived adipocytes (hMSC-Adi) after 0, 7, 14, and 21 days of differentiation. Scale bars: 100 μm.
(B) RT-qPCR analysis of PPARγ, Leptin, CEBPα and CEBPδ in 0, 7, 14, and 21 days-differentiated adipocytes. Transcript levels of GAPDH were used
for sample normalization. Data was obtained from 4 independent experiments (Bars: median ± interquartile space). Differences were considered
significant at p < 0.05 (*p < 0.05, **p < 0.01). (n. d. not detected). (C) RT-qPCR of miR-138, miR-30c, miR-125a, miR-125b, miR-31 in 0 and 14
days-differentiated adipocytes. Transcript levels of RNU6P were used for sample normalization. (D) RT-qPCR analysis of PPARγ in 14 days-differentiated
adipocytes (hAdi D14) transfected with siPPARγ or with non-target control siRNA (siCTRL). Transcript levels of 36B4 were used for sample normalization.
(E) RT-qPCR analysis of PPARγ in 14 days-differentiated osteoblasts incubated with conditioned medium from 0 (ctrl) or 14 days-differentiated
adipocytes transfected (hAdi D14 siPPARγ-CM) or not (hAdi D14-CM). Transcript levels of 36B4 were used for sample normalization.
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method of differential centrifugation and filtration [30].
The obtained hMSC-Adi EVs were observed under
transmission electron microscopy, which revealed that
they are approximately 30–100 nm in size (Figure 3A).
RNAs were then isolated from these EVs at the differen-
tiation times of their adipocytes of origin. As shown in
Figure 3B, RT-qPCR experiments revealed that EVs hold
as proportional amounts of specific mRNA as hMSC-
Adi expressed depending on the differentiation stage.
For example, no mRNA coding for leptin was detected
in EVs isolated from the non-differentiated adipocyte
(day 0) CM, as found in the cells of origin (Figure 2B,
day 0). We also noticed the same maximum increase at
day 7 of differentiation, maintained at day 14 and 21, of
CEBPα and CEBPδ mRNAs in EVs as in hMSC-Adi.
Finally, we observed a similar expression of each ofthese mRNAs in EVs and in hMSC-Ost incubated with
hAdi-CM. These results suggest that EVs could be the
vehicle by which adipogenic mRNAs are transferred to
osteoblasts.
Species-specific adipogenic mRNAs are transferred from
adipocytes to osteoblasts
To carry out inter-species experiments, hMSC-Adi CM
was applied to the mouse cell line MC3T3-derived oste-
oblasts and RT-qPCR was performed with highly specific
human primers against adipocyte specific genes. Each of
these primers were tested on mouse RNA for their spe-
cificity (data not shown). hGAPDH and h36B4 genes,
usually used as reference genes, were chosen as they are
known to be commonly found in EVs [19]. As shown in
Figure 4A, the human adipocyte genes hPPARγ, hLeptin
and hCEBPδ were specifically amplified from RNA
Figure 3 Morphologic observation and adipocyte-specific mRNA quantification of EVs isolated from CM obtained from adipocytes after
14 days of differentiation. (A) Images obtained by transmission electron microscopy on the EVs collected at day 14 of adipocyte differentiation
of hMSC, after negative coloration by uranyl oxalate. Scale bars: 200 and 100 nm. (B) RT-qPCR analysis of PPARγ, Leptin, CEBPα and CEBPδ in EVs
isolated from 0, 7, 14, and 21 days-differentiated adipocytes. Transcript levels of GAPDH were used for sample normalization.
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RNAs were found to be amplified. These results confirm
the hypothesis of a mRNA transfer from adipocytes to
osteoblasts.
To strengthen these results, the reverse experiment was
performed. Mouse bone marrow primary cells were ob-
tained as described in Materials and Methods and were
differentiated into adipocytes during 14 days (mBM-Adi
D14). Observation by optical microscopy (Figure 4B)
showed the appearance of lipid droplets confirming the
adipocytic differentiation. Conditioned medium of mBM-
Adi D14 (mBM-Adi D14 CM) was applied to hMSC-Ost
and amplification of the mouse genes mPPARγ, mAdipo-
nectin and mCEBPα was performed using highly specific
primers as well (Figure 4C). Although a non-specific
amplicon, especially for mPPARγ and mAdiponectin, ap-
peared for hMSC-Ost D14, this happened in all condi-
tions, confirming the non-specificity of the band. For both
mRNA, a specific band at the right size is observed, only
when hMSC-Ost D14 were incubated with mBM-Adi D14
CM. Moreover mBM-Adi D14 were used as a positive
control for mouse genes amplification, showing a unique
band at the corresponding size, confirming the specificity
of the primers for the mouse PPARγ and Adiponectin
mRNAs. mGAPDH and mActin genes were used as refer-
ence genes commonly found in EVs [19]. Taken together,
these results highlighted that the three adipocyte specific
mouse mRNAs mPPARγ, mAdiponectin and mCEBPα as
well as mGAPDH and mActin were found in hMSC-Ost
incubated with mBM-Adi D14 CM, supporting transfer of
mRNAs from adipocyte derived from bone marrow
primary cells.Discussion
The increase in marrow adipocytes observed in osteo-
porosis may contribute to limiting of osteoblast commit-
ment by acting on MSCs or even directly on osteoblasts
[31]. This hypothesis is supported by the proximity of
adipocytes to osteoblasts in the bone marrow, their
shared mesenchymal progenitor origin, and the fact that
adipocytes are secretory cells. In an attempt to repro-
duce cellular interactions within the bone marrow, our
group previously developed a coculture system using
hMSC-derived osteoblasts and adipocytes [18]. In this
model, a negative influence of adipocytes on osteoblast
differentiation has been observed, supporting this as-
sumption. Bone marrow adipocytes are highly secreting
cells and, amongst factors such as fatty acids and adipo-
kines already described in vitro to modify their neigh-
bouring cells [32-34], we wonder if other mediators
could be implicated. Within the past decade, EVs have
emerged as important factors in intercellular communi-
cation, being involved in the transmission of biological
signals between cells [19,35]. EVs components may in-
clude proteins, mRNAs and miRNAs. These compo-
nents can be delivered to neighbouring cells and can be
functional in their new location. The protein and RNA
composition of EVs depends on the cell type or tissue
source from which they originate. Although EVs are re-
leased from many cell types, to our knowledge no study
has reported their secretion by hMSC-derived adipocytes.
In this study we could show that hMSC-Adi secrete
EVs containing adipocyte specific mRNAs and anti-
osteogenic miRNAs, that can be transferred to osteo-
blasts. Morphologically, the obtained EVs look quite
Figure 4 Species-specific adipogenic mRNAs observation in
osteoblasts incubated in different species adipocytes conditioned
medium. (A) Agarose gel electrophoresis of RT-PCR products of
hPPARγ, hLeptin, hCEBPδ, hGAPDH and h36B4 from 14 days-differentiated
MC-3 T3 (MC3T3 D14) incubated with conditioned medium from
14 days-differentiated human adipocytes (hMSC-Adi D14 CM). Two
representative experiments are shown (1 and 2). Positive control was
performed on hMSC-Adi D14 and negative control was obtained by
incubating MC3T3 D14 with serum- and inductors-free DMEM for the
same time (ctrl). (B) Images obtained by optical microscopy on mouse
bone marrow-derived adipocytes (mBM-Adi) after 14 days of
differentiation. Scale bar: 100 μm. (C) Agarose gel electrophoresis of
RT-PCR products of mPPARγ, mAdiponectin, mCEBPα, mGAPDH and
mActin from 14 days-differentiated human osteoblasts (hMSC-Ost D14)
incubated with conditioned medium from 14 days-differentiated
mouse adipocytes (mBM-Adi D14 CM). Two representative experiments
are shown (1 and 2). Positive control was performed on mBM-Adi D14
and negative control was obtained by incubating hMSC-Ost D14 with
serum- and inductors-free DMEM for the same time (ctrl).
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profile remains to be characterized to classify them
either as exosomes or as ectosomes [36,37]. Both aremembrane bound vesicles that differ based on their
process of biogenesis, and biophysical properties, such
as size and surface protein markers.
A significant increase of PPARγ, CEBPα and CEBPδ
expression in osteoblasts incubated with hAdi-CM could
be measured, suggesting an adipocyte-specific mRNA
transfer. This hypothesis is corroborated by: (i) the pre-
sence of these transcripts in EVs, (ii) the fact that silen-
cing of PPARγ mRNA in donor adipocytes inhibits the
increase of PPARγ mRNA observed in the recipient os-
teoblasts after incubation in hAdi CM and (iii) the inter-
species experiments, except for hCEBPα to mouse cells
and mCEBPδ to human cells because of difficulties to
optimize specific PCR. Besides, the genes used as con-
trols, GAPDH, 36B4 and Actin, that are known to be
found in EVs [19], are also transferred to their target
cells (Figure 4A and C), corroborating the hypothesis of
transcripts passage through EVs. Nonetheless, the bands
observed in MC3T3 D14 incubated with hAdi D14 CM
are slight and poorly reproducible, especially for hPPARγ
and hLeptin. This can be explained by the fact that only
a small quantity of human transcripts is transferred. For
this reason, the observed amplification should be consid-
ered as qualitative more than quantitative. Concerning
adiponectin, a time-dependent induction of its expression
in hAdi could be measured, but no increase could be ob-
served in human osteoblasts incubated with hAdi-CM
(data not shown). However, a transfer of mouse adiponec-
tin mRNA could be detected in hOst incubated with CM
mBM-Adi by specific PCR.
An increase of miR-30c and miR-31 miRNAs, target-
ing osteogenic transcripts such as RUNX2 and Osterix,
[23,26-28] and of miR-125a known to be significantly
downregulated during osteogenic differentiation in hu-
man adipose-derived stem cells [38] and predicted to
target the osteogenic genes Smad 2 and 4 [39], could be
found in hOst incubated with hAdi-CM. However, no
decrease of the expression of Runx2 and Osterix could
be observed (data not shown) as described in studies
using cells overexpressing these miRNAs [23,25,27,28].
In our case, the slight induction of each miRNA ob-
served in hOst incubated with hAdi-CM is maybe not
sufficient to reproduce a significant repression of Runx2
and Osterix. Nonetheless we could detect a small de-
crease of the late osteoblastic marker transcripts OC et
OP. These were found to be targeted by miR-125b and
miR-138 [23,40], two miRNAs that we have shown to be
increased in hOst incubated with hAdi-CM, suggesting
that the transferred miRNAs are functional. However
their putative role in our model should be investigated
in depth.
As RNA transfer between hMSC-derived adipocytes
and hMSC-derived osteoblasts could be shown, we fur-
ther examined whether EVs were directly implicated.
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CM and no adipogenic RNA increase could be found in
hMSC-Ost (data not shown). This result might be attri-
buted to the loss of part of the EVs and/or of their func-
tional effect during the isolation procedure. Another
possible explanation is that EVs are not the only way in
which adipocytes may influence osteoblast gene expres-
sion and maybe some adipocytes-secreted molecules are
needed in the medium to enhance their effects. Further
study is required to answer these questions.
Conclusions
Here, we have shown for the first time that RNA transfer is
possible between hMSC-derived adipocytes and osteoblasts
through EVs. Additional studies are needed to clarify if this
mechanism has a role in the adipocytic switch driven on
osteoblasts by adipocytes inside bone marrow and if EVs
could be a target component to regulate the competition
between osteoblasts and adipocytes in the prevention or in
the therapy of osteoporosis and other osteopenia.
Methods
Cell culture experiments
Human MSC culture and induction of osteogenic and
adipogenic differentiation
Purified MSCs were purchased from Lonza (Verviers,
Belgium) and were cultured as described previously [18].
Differentiation experiments were started when hMSCs
had reached confluence (D0). To induce osteogenesis,
hMSCs were cultured in DMEM with 10% FCS supple-
mented with osteogenic inductors (50 μM ascorbic acid,
10 mM β-glycerophosphate and 10−8 M vitamin D3
(Sigma-Aldrich Corporation, St Quentin Fallavier, France))
for 14 days (hMSC-Ost). For adipogenic differentiation,
hMSCs were cultured in DMEM with 10% FCS sup-
plemented with adipogenic inductors (0.5 μM dexame-
thasone, 0.5 mM isobutyl-1-methylxanthine and 50 μM
indomethacin (Sigma-Aldrich Corporation)) for 0, 7, 14 or
21 days (hMSC-Adi).
MC3T3 culture and osteogenic differentiation
The MC3T3-E1 cells were plated in expansion medium
composed of alpha-Modified Eagle Medium (α-MEM)
(Dutscher) containing 10% FCS, 1% penicillin/streptomycin
and 1% glutamine (Dutscher). Osteogenesis differentiation
was started when MC3T3 had reached confluence (day 0)
by incubation with osteogenic inductors (50 μg/ml ascor-
bic acid and 10 mM β-glycerophosphate (Sigma-Aldrich
Corporation) for 14 days.
Primary mice bone marrow cell culture and adipogenic
differentiation
Female C57BL6 mice, 7 weeks of age, were purchased
from Charles River and were acclimatized for 1 weekunder standard laboratory conditions. Immediately after
sacrifice, femurs and tibias were removed and cleaned of
connective tissue, the ends were cut, and the marrow
was flushed with α-MEM (PAN Biotech, Dutsher) sup-
plemented with 15% FCS (PAN Biotech), 2 mM of glu-
tamine (PAN Biotech), 50 IU/ml of penicillin (PAN
Biotech), and 50 μg/ml of streptomycin (PAN Biotech).
Single-cell suspensions were prepared in α-MEM by
drawing the cells several times through graded needles.
Cell density was determined using a Malassez counting
chamber. For all experiments, cells were plated at a
density of 2 × 106 cells/cm2 and incubated at 37°C in 5%
CO2. After 24 hours, non-adherent cells were removed
and the medium was changed every 3 days until cell
confluence.
Adipogenesis was induced by DMEM (PAN Biotech)
10% FCS supplemented with 10 μg/ml insulin/0,5 μM
dexamethasone/100 μM indomethacin/500 μM 3-isobutyl-
1-methylxanthine (Sigma-Aldrich Corporation) for 4 days
and maintained in 10 μg/ml insulin/0,5 μM dexametha-
sone/5 μM pioglitazone (Sigma-Aldrich Corporation) for
10 days (mBM-Adi).
Conditioned medium (CM) experiments
After adipogenic differentiation of hMSCs or mouse
bone marrow derived cells for the indicated times, differ-
entiation medium was discarded and replaced with
serum- and inductors-free DMEM containing antibiotics
for 48 h and collected (hAdi-CM or mBM-Adi CM).
1 ml of CM was then applied on DMEM rinsed hMSC-
or MC3T3-derived osteoblasts cultured in 12-well plates
and incubated for 48 h. As controls, osteoblasts were in-
cubated with serum- and inductors-free DMEM for the
same time.
Small interfering RNA (siRNA) transfection
RNA interference was used to knockdown the expression
of PPARγ in hMSC-Adi. siRNA for PPARγ (siPPARγ) and
non-target controls were designed and synthesized by
Dharmacon (ABgene Ltd, United Kingdom) and distri-
buted by Thermo Fisher Scientific (PPARG Accell
SMART pool, E-003436 and Accell control siRNA kit, K-
005000). hAdi D14 were transfected with siRNAs (1 μM)
for 72 h according to the manufacturer’s instructions.
hMSC-Ost were incubated 48 h in conditioned medium
from hMSC-Adi transfected (hAdi D14 siPPARγ-CM) or
not (hAdi-CM) with siPPARγ.
Extracellular vesicles (EVs) isolation
hMSC-derived adipocytes (hMSC-Adi) at the indicated
times of differentiation (D0, D7, D14, D21) were incu-
bated in EVs-free DMEM and the obtained conditioned
medium from 1.5 × 107 cells was collected after 48 h.
EVs were purified by differential centrifugation and
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Adi-conditioned medium (hAdi-CM) was centrifuged for
10 min at 2000 g to eliminate cell contamination. Super-
natants were further centrifuged for 20 min at 3500 g,
filtered through a 0.45 μm filter and concentrated thanks
to Amicon Ultra-15 Centrifugal Filter Units with 10 kDa
cut-off (Millipore). EVs were pelleted by ultracentrifuga-
tion at 110,000 g for 70 min. The EV pellets were either





hPPARγ F: 5′-GCTTCTGGATTTCACTATGG-3′ NM_005037
R: 5′-AAACCTGATGGCATTATGAG-3′
hLeptin F: 5′-ATTTCACACACGCAGTCAGT-3′ NM_00230
R: 5′-GAAGAAGATCCCGGAGGT-3′
hCEBPα F: 5′-ACTGGGACCCTCAGCCTTG-3′ NM_004364
R: 5′-TGGACTGATCGTGCTTCGTG-3′
hCEBPδ F: 5′-ACGACGACGAGAGCGCCATC-3′ NM_005195
R: 5′-CGCCCGCCTTGTGATTGC-3′
hOC F: 5′-ATGAGAGCCCTCACACTCCTC-3′ NM_199173
R: 5′-GCCGTAGAAGCGCCGATAGGC-3′
hOP F: 5′-CCTGCCAGCAACCGAAGTTT-3′ NM_001040058.1
R: 5′-ACTGTCCTTCCCACGGCTGT-3′
hYWHAZ F: 5′-GGTCATCTTGGAGGGTCGTC-3′ NM_145690
R: 5′-GTCATCACCAGCGGCAAC-3′
hGAPDH F: 5′-GTTCCAATATGATTCCACCC-3′ NM_002046.5
R: 5′-AGGGATGATGTTCTGGAGAG-3′




mPPARγ F: 5′-TTTTCAAGGGTGCCAGTTTC-3′ NM_001127330
R: 5′-AATCCTTGGCCCTCTGAGAT-3′
mAdiponectin F: 5′-CCCAGTCATGCCGAAGA-3′ NM_009605.4
R: 5′-TACATTGGGAACAGTGACGC-3′
mCEBPα F: 5′-TTACAACAGGCCAGGTTTCC-3′ NM_007678
R: 5′-CTCTGGGATGGATCGATTGT-3′
mGAPDH F: 5′-GGCATTGCTCTCAATGACAA-3′ NM_008084
R: 5′-TGTGAGGGAGATGCTCAGTG-3′
mActin F: 5′-AATTTCTGAATGGCCCAGGT-3′ NM_007393
R: 5′-GGTAAGGTGTGCACTTTTATTGG-3′
Shown are the primer sequences and Genbank accession numbers. F: forward;
R: reverse. h: human; m: mouse. PPARγ, peroxisome proliferator-activated
receptor gamma; CEBPα and δ, CCAAT/enhancer binding protein alpha and
delta; YWHAZ, tyrosine 3-monooxygenase/tryptophan 5- monooxygenase
activation protein, GAPDH, Glyceraldehyde 3-phosphate dehydrogenase.




Total RNA was extracted using Extract-All reagent
(Eurobio, Les Ulis, France), according to the manufac-
turer’s instructions. Total RNA was digested with DNase
I (Roche Diagnostics, Meylan, France) and quantified by
Nanodrop at 260 nm wavelength.
mRNAs expression analysis
Total RNA was reverse transcribed using Maxima First-
Strand cDNA Synthesis kit (Fermentas, Thermoscientific,
France), and subjected to quantitative real-time PCR on the
LightCycler® Carousel-Based System (Roche Diagnostics)
using the LightCycler® Fast Start DNA Master SYBR® Green
I kit as described previously and specific primers designed
using Oligo 6 software (MedProbe, Oslo, Norway) (Table 1)
[16]. Results were normalized against expression of the in-
dicated genes and compared to the expression level as base-
line by the 2-ΔΔCt method, and log2-transformed fold
changes of normalized 2-deltaCT.
For interspecies experiments, subsequent PCR pro-
ducts were migrated on 1.8% agarose gel for visualization.
miRNA expression analysis
Total RNA was reverse transcribed using the miScript II
RT Kit (Qiagen), and subjected to quantitative real-time
PCR on the LightCycler® Nano System (Roche Diagnotics)
using the miScript SYBR Green PCR Kit (Qiagen) accor-
ding to the manufacturer’s instructions. Specific primers
are listed in Table 2. Results were normalized against
RNU6P expression and compared to the expression level
as baseline by the 2-ΔΔCt method, and log2-transformed
fold changes of normalized 2-deltaCT.
Electron microscopy of EVs
EVs from hMSC-Adi were labeled as described by Thery
et al. [29]. Briefly, they were fixed in 2% parafor-
maldehyde in PBS, loaded onto formvar carbon-coated
grids and incubated during 20 minutes. After extensiveTable 2 miRNA primer sequences








Shown are the primer sequences and Genbank accession numbers.
Martin et al. BMC Cell Biology  (2015) 16:10 Page 9 of 10washing with PBS, EVs were postfixed in 1% glutaralde-
hyde for 5 min, extensively washed in distilled water and
embedded in a mixture of uranyl acetate and methyl cel-
lulose for negative coloration. They were then examined
in a Zeiss 902, 80 kV transmission electron microscope.
Statistical analysis
Results are expressed as median of experimental data,
using quartiles [Q1;Q3] to evaluate variability around this
value. All statistical comparisons were made using a non-
parametric Mann–Whitney U-Test, using SPSS software
version 18. Differences were considered significant at
p < 0.05 (*p < 0.05, **p < 0.01).
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